ZFAND5
AN1-type zinc finger protein 5
Also known as: ZA20D2, ZFAN5_HUMAN, ZFAND5A, ZNF216
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76080
- Gene
- ZFAND5
- Ensembl
- ENSG00000107372
- Chromosome
- 9
- Canonical length
- 213 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to act upstream of or within several processes, including face development; fibroblast migration; and platelet-derived growth factor receptor signaling pathway. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
213 residues, UniProt reviewed canonical sequence.
>O76080|ZFAND5
1 MAQETNQTPG PMLCSTGCGF YGNPRTNGMC SVCYKEHLQR QQNSGRMSPM GTASGSNSPT
61 SDSASVQRAD TSLNNCEGAA GSTSEKSRNV PVAALPVTQQ MTEMSISRED KITTPKTEVS
121 EPVVTQPSPS VSQPSTSQSE EKAPELPKPK KNRCFMCRKK VGLTGFDCRC GNLFCGLHRY
181 SDKHNCPYDY KAEAAAKIRK ENPVVVAEKI QRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZFAND5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 561 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 561 nTPM
- adipose tissue: 293 nTPM
- blood vessel: 266 nTPM
- tongue: 256 nTPM
- ovary: 235 nTPM
- liver: 191 nTPM
Single-cell type
- epididymal basal cells: 1,214 nCPM
- esophageal apical cells: 967 nCPM
- thymic myoid cells: 771 nCPM
- ocular epithelial cells: 653 nCPM
- neutrophils: 644 nCPM
- endometrial glandular cells: 627 nCPM
Immune cell
- non-classical monocyte: 82 nTPM
- intermediate monocyte: 52 nTPM
- basophil: 39 nTPM
- eosinophil: 37 nTPM
- classical monocyte: 36 nTPM
- myeloid DC: 34 nTPM
Brain region
- midbrain: 171 nTPM
- basal ganglia: 166 nTPM
- hypothalamus: 160 nTPM
- white matter: 159 nTPM
- thalamus: 156 nTPM
- pons: 155 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ZFAND5.
Disease | ImmuneIEDB
Conditions an epitope on ZFAND5 was assayed in.
- chronic lymphocytic leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- face development
- fibroblast migration
- in utero embryonic development
- platelet-derived growth factor receptor signaling pathway
- respiratory system process
- skeletal system morphogenesis
- smooth muscle tissue development
- vasculature development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZFAND5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZFAND5 as an antibody target. Whether an autoantibody or antibody against ZFAND5 could matter depends on whether native ZFAND5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZFAND5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZFAND5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...